Ethan Park

Part of Celtic Holdings SCA, Alvogen Emerging Markets Holdings Ltd. is a Chinese pharmaceutical company that offers high-quality, affordable generic medications to reduce healthcare costs globally. The company is based in Wanchai, Hong Kong. The company's growth strategy is fueled by a unique portfolio of high-quality and difficult-to-make pharmaceutical products. Alvogen's sister company, Alvotech, specializes in the development and manufacturing of high-quality biosimilar medicines. The company was founded in 2009 by Vilhelm Róbert Wessman, who has been the CEO since 2009.

Part of Celtic Holdings SCA, Alvogen Emerging Markets Holdings Ltd. is a Chinese pharmaceutical company that offers high-quality, affordable generic medications to reduce healthcare costs globally. The company is based in Wanchai, Hong Kong. The company's growth strategy is fueled by a unique portfolio of high-quality and difficult-to-make pharmaceutical products. Alvogen's sister company, Alvotech, specializes in the development and manufacturing of high-quality biosimilar medicines. The company was founded in 2009 by Vilhelm Róbert Wessman, who has been the CEO since 2009.

Part of Celtic Holdings SCA, Alvogen Emerging Markets Holdings Ltd. is a Chinese pharmaceutical company that offers high-quality, affordable generic medications to reduce healthcare costs globally. The company is based in Wanchai, Hong Kong. The company's growth strategy is fueled by a unique portfolio of high-quality and difficult-to-make pharmaceutical products. Alvogen's sister company, Alvotech, specializes in the development and manufacturing of high-quality biosimilar medicines. The company was founded in 2009 by Vilhelm Róbert Wessman, who has been the CEO since 2009.

Part of Celtic Holdings SCA, Alvogen Emerging Markets Holdings Ltd. is a Chinese pharmaceutical company that offers high-quality, affordable generic medications to reduce healthcare costs globally. The company is based in Wanchai, Hong Kong. The company's growth strategy is fueled by a unique portfolio of high-quality and difficult-to-make pharmaceutical products. Alvogen's sister company, Alvotech, specializes in the development and manufacturing of high-quality biosimilar medicines. The company was founded in 2009 by Vilhelm Róbert Wessman, who has been the CEO since 2009.

Part of Celtic Holdings SCA, Alvogen Emerging Markets Holdings Ltd. is a Chinese pharmaceutical company that offers high-quality, affordable generic medications to reduce healthcare costs globally. The company is based in Wanchai, Hong Kong. The company's growth strategy is fueled by a unique portfolio of high-quality and difficult-to-make pharmaceutical products. Alvogen's sister company, Alvotech, specializes in the development and manufacturing of high-quality biosimilar medicines. The company was founded in 2009 by Vilhelm Róbert Wessman, who has been the CEO since 2009.